Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.1% Tacrolimus in the Treatment of Sjogren's Syndrome Dry Eye
ChiCTR-OIB-16007789Phase 4Recruiting
- Sponsor
- Eye Institute of Xiamen University
- Start
- Jan 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in Sjögren's syndrome and dry eye syndrome (DED), sponsored by Eye Institute of Xiamen University. Primary endpoints: Dry eye questionnaire score, Vision and 12 more. Started Jan 2016; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
Sjögren's syndromedry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR-OIB-16007789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIB-16007789.